Lecturer Malia Lazu writes for Banker & Tradesman about how the Massachusetts Bay Transportation Authority needs to reestablish its relationship with the state and its citizens. “Making a major investment in transportation should not be seen as social service and a waste of tax dollars, but as economy building,” writes Lazu.
Prof. Mircea Dincă and Grama Sorin co-founded Transaera, a company dedicated to designing air conditioners that require significantly less energy, reports Scott Kirsner for The Boston Globe. “Grama and Dincă cofounded Transaera in 2018 and supported their early work with about $2 million in state and federal grants, from agencies that included the Massachusetts Clean Energy Center,” writes Kirsner.
Joseph Coughlin, Director of the MIT AgeLab, writes for Forbes about Serena William’s recent retirement announcement and the evolving concept of retirement. “Tennis star Serena Williams announced her ‘retirement’ from tennis this week while challenging the very idea of retirement,” writes Coughlin. “Williams is not alone. Many people, far older than her 41 years, are declaring retirement a dated term best left to past generations and another era.”
A new proposed economic bill could provide “game-changing” incentives for the nuclear energy industry, reports Jennifer McDermott and Mary Katherine Wildeman for the Associated Press. The bill “is really substantial,” says Prof. Jacopo Buongiorno. “This should move the needle in terms of making these technologies economically viable right off the bat.”
Researchers at MIT have found that “for every nine adults who gained access to Medicaid in Oregon due to a special due to a special enrollment lottery, one previously eligible child was added to the rolls as well,” reports Dennis Thompson for U.S. News & World Report. The lottery “enabled us to look at the questions of what happens to children of adults who win the lottery, compared to children of adults who don’t win the lottery,” says Prof. Amy Finkelstein.
Reuters reporter Nancy Lapid writes that MIT researchers have developed an at-home test that can measure a person’s antibody levels to the virus that causes Covid-19. The test could someday “help people know how protected they are against infection and what kinds of precautions they need to take,” writes Lapid.
MIT researchers have developed firefly-inspired robots that can emit light while flying, reports Popular Mechanics. “The robots may be able to converse with one another because of this electroluminescence and, for instance, a robot that finds survivors while on a search-and-rescue mission, within a fallen building, could use lights to alert others and request assistance.”
The Emerald Tutu, a climate resiliency project in Boston led by Gabriel Cira ’08, is developing a system of floating wetlands designed to reduce coastal flooding by knocking down waves, reports Hannah Chanatry for WBUR. The Emerald Tutu was the winning project at the 2018 MIT Climate Changed Ideas competition. “Fundamentally, it’s like a giant sponge that fits around urban coastlines like we have here in Boston,” said Cira. “It buffers those coastlines from the intense effects of coastal storms.”
Hojun Li, a clinical investigator at the Koch Institute, speaks with Juli McDonald on CBS Boston about his efforts to develop a test that can determine a person’s Covid immunity. “We wanted to develop a way in which we could very quickly and easily assess whether [immunocompromised people] were still protected from that vaccine or that previous infection they had,” said Li.
Daily Beast reporter Tony Ho Tran writes that a new paper test developed by MIT researchers could be used to help determine a person’s immune response to Covid-19. “The researchers believe that the new test can not only help folks find out if they should get boosted,” writes Tran, “but also help the most vulnerable populations make sure they’re protected against the coronavirus, and help people make more informed decisions on what kinds of activities they should feel safe doing.”
Boston.com reporter Madeleine Aitken writes that MIT researchers have created a new blood test that can measure immune protection against Covid-19. The new test measures the “level of neutralizing antibodies in a blood sample, using the same type of ‘lateral flow’ technology as antigen tests,” writes Aitken.
Researchers from MIT and Harvard have developed a “3D-printed ‘lab-on-a-chip’ that could detect Covid-19 immunity levels and Covid infections from saliva within two hours,” reports Ben Leonard and Ruth Reader for Politico.
Fast Company reporter Elissaveta Brandon writes that a team of scientists from MIT and elsewhere have developed an amphibious artificial vision system inspired by the fiddler crab’s compound eye, which has an almost 360-degree field of view and can see on both land and water. “When translated into a machine,” writes Brandon, “this could mean more versatile cameras for self-driving cars and drones, both of which can become untrustworthy in the rain.”
Nature reporter Neil Savage spotlights Prof. Michael Strano’s work developing a new technique to use nanoparticles to alter the biology of living plants. Savage writes that the new technique can allow for "the design of nanoparticles that carry gene-editing machinery to targeted areas to rewrite the plant’s genome and imbue it with properties such as pest and disease resistance,” writes Savage.
Prof. Andrew Lo speaks with Forbes contributor Russell Flannery about his work using finance to help lower the cost of drug development for cancer treatment and therapies. “I started thinking about how we could use finance pro-actively to lower the cost of drug development, increase success rates, and make it more attractive for investors,” says Lo. “Because that's really what the issue is: you need investors to come into the space to spend their billions of dollars in order to get these drugs developed.”